Stockreport

Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research

Tempus AI, Inc. - Class A  (TEM) 
PDF Tempus Launches Its First Study With a Nonprofit Foundation Collaborator to Create Robust FL Dataset CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a techno [Read more]